Nearly 90,000 bottles of Children’s Ibuprofen are recalled due to foreign particles; no serious illnesses reported.

Nearly 90,000 bottles of Children’s Ibuprofen Oral Suspension, 100 mg per 5 mL, are being recalled nationwide due to reports of a gel-like substance and black particles in the product. The recall, initiated by Taro Pharmaceuticals U.S.A. Inc. and classified as Class II by the FDA, affects lots 7261973A and 7261974A with an expiration date of January 31, 2027. Consumers are advised to stop using the product immediately, check lot numbers, and return bottles for a refund. No illnesses have been reported, but the FDA warns of potential temporary health issues. The medication is not recommended for infants under six months.